{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T20:09:07Z","timestamp":1783973347592,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["801342"],"award-info":[{"award-number":["801342"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GR 2232\/9-1"],"award-info":[{"award-number":["GR 2232\/9-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TH 2320\/3-1"],"award-info":[{"award-number":["TH 2320\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHO 2052\/1-1"],"award-info":[{"award-number":["SCHO 2052\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["514598754"],"award-info":[{"award-number":["514598754"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["374031971-TRR240"],"award-info":[{"award-number":["374031971-TRR240"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2024_EKSP.172"],"award-info":[{"award-number":["2024_EKSP.172"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022217","name":"Flinders Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022217","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jtha.2026.01.016","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:33:53Z","timestamp":1770770033000},"page":"1871-1880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of monoclonal and patient-derived antiplatelet factor 4 antibodies in platelet factor 4 and platelet factor 4\/polyanion chemiluminescence assays"],"prefix":"10.1016","volume":"24","author":[{"given":"Venkata A.S.","family":"Dabbiru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Broto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Wesche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Gebicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Rollin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Gruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Palicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8343-7336","authenticated-orcid":false,"given":"Andreas","family":"Greinacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Sch\u00f6nborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.01.016_bib1","doi-asserted-by":"crossref","first-page":"8361","DOI":"10.1021\/bi00193a025","article-title":"Crystal structure of recombinant human platelet factor 4","volume":"33","author":"Zhang","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.jtha.2026.01.016_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2022.02.005","article-title":"Platelet-activating anti-PF4 disorders: an overview","volume":"59","author":"Warkentin","year":"2022","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtha.2026.01.016_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ijlh.14075","article-title":"Platelet factor 4 triggers thrombo-inflammation by bridging innate and adaptive immunity","volume":"45","author":"Greinacher","year":"2023","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.jtha.2026.01.016_bib4","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.016_bib5","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.016_bib6","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1056\/NEJMoa2104882","article-title":"Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination","volume":"384","author":"Schultz","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.016_bib7","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1056\/NEJMoa2109908","article-title":"Clinical features of vaccine-induced immune thrombocytopenia and thrombosis","volume":"385","author":"Pavord","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.016_bib8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJMc2307721","article-title":"Adenovirus-associated thrombocytopenia, thrombosis, and VITT-like antibodies","volume":"389","author":"Warkentin","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.016_bib9","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMc2402592","article-title":"Antibody fingerprints linking adenoviral anti-PF4 disorders","volume":"390","author":"Wang","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.016_bib10","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMc2409428","article-title":"Diagnostic complexity in monoclonal gammopathy of thrombotic significance","volume":"391","author":"Kanack","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.016_bib11","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1182\/blood.2022018797","article-title":"Monoclonal gammopathy of thrombotic\/thrombocytopenic significance","volume":"141","author":"Kanack","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.016_bib12","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3324\/haematol.2021.280366","article-title":"Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy","volume":"107","author":"Greinacher","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.01.016_bib13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMoa2415930","article-title":"VITT-like monoclonal gammopathy of thrombotic significance","volume":"392","author":"Wang","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.016_bib14","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1182\/blood.V91.3.916","article-title":"Antibodies from patients with heparin-induced thrombocytopenia\/thrombosis recognize different epitopes on heparin: platelet factor 4","volume":"91","author":"Suh","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.016_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-2141.1996.d01-1876.x","article-title":"The epitope specificity of heparin-induced thrombocytopenia","volume":"95","author":"Horsewood","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.01.016_bib16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1182\/bloodadvances.2022007336","article-title":"Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S","volume":"7","author":"Huynh","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.01.016_bib17","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41586-021-03744-4","article-title":"Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia","volume":"596","author":"Huynh","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jtha.2026.01.016_bib18","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/jth.13786","article-title":"5B9, a monoclonal antiplatelet factor 4\/heparin IgG with a human Fc fragment that mimics heparin-induced thrombocytopenia antibodies","volume":"15","author":"Kizlik-Masson","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.016_bib19","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1182\/blood.V95.5.1533.005k01_1533_1540","article-title":"Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies","volume":"95","author":"Arepally","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.016_bib20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1055\/s-0040-1717078","article-title":"Characterization of new monoclonal PF4-specific antibodies as useful tools for studies on typical and autoimmune heparin-induced thrombocytopenia","volume":"121","author":"Vayne","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.016_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/vaccines13010003","article-title":"Recombinant anti-PF4 antibodies derived from patients with vaccine-induced immune thrombocytopenia and thrombosis (VITT) facilitate research and laboratory diagnosis of VITT","volume":"13","author":"M\u00fcller","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.jtha.2026.01.016_bib22","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1182\/blood.2023021307","article-title":"Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT","volume":"143","author":"Wang","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.016_bib23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/jth.15560","article-title":"Multicentre evaluation of 5B9, a monoclonal anti-PF4\/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: communication from the ISTH SSC Subcommittee on Platelet Immunology","volume":"20","author":"Pouplard","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.016_bib24","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1111\/jth.14749","article-title":"Evaluation of functional assays for the diagnosis of heparin induced thrombocytopenia using 5B9, a monoclonal IgG that mimics human antibodies","volume":"18","author":"Vayne","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.016_bib25","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1182\/bloodadvances.2023009661","article-title":"Treatment of thrombocytopenia and thrombosis in HIT in mice using deglycosylated KKO: a novel therapeutic?","volume":"7","author":"Sarkar","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.01.016_bib26","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1182\/blood.2019001133","article-title":"FcRn augments induction of tissue factor activity by IgG-containing immune complexes","volume":"135","author":"Cines","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.016_bib27","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1160\/TH16-01-0074","article-title":"Immune pathogenesis of heparin-induced thrombocytopenia","volume":"116","author":"Khandelwal","year":"2016","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.016_bib28","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3324\/haematol.2021.280251","article-title":"The deglycosylated form of 1E12 inhibits platelet activation and prothrombotic effects induced by VITT antibodies","volume":"107","author":"Vayne","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.01.016_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-0042-1758818","article-title":"Laboratory testing for heparin-induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia antibodies: a narrative review","volume":"49","author":"Warkentin","year":"2023","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.01.016_bib30","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1182\/blood.2023022136","article-title":"Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure","volume":"142","author":"Sch\u00f6nborn","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.016_bib31","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1182\/blood.V99.4.1230","article-title":"Defining a second epitope for heparin-induced thrombocytopenia\/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody","volume":"99","author":"Li","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.016_bib32","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1182\/blood-2012-01-407262","article-title":"Dynamic antibody-binding properties in the pathogenesis of HIT","volume":"120","author":"Sachais","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.016_bib33","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jtha.2024.05.005","article-title":"The use of 1E12, a monoclonal anti-platelet factor 4 antibody, to improve the diagnosis of vaccine-induced immune thrombotic thrombocytopenia","volume":"22","author":"Vayne","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.016_bib34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1046\/j.1365-2141.1997.4183225.x","article-title":"Differences in specificity of heparin-dependent antibodies developed in heparin-induced thrombocytopenia and consequences on cross-reactivity with danaparoid sodium","volume":"99","author":"Pouplard","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.01.016_bib35","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1111\/jth.15848","article-title":"Variable serotonin release assay pattern and specificity of PF4-specific antibodies in HIT, and clinical relevance","volume":"20","author":"Rollin","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.016_bib36","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1182\/bloodadvances.2024015095","article-title":"Cooperative effect between anti-PF4\/H and anti-PF4 antibodies increases cell activation and thrombotic risk in HIT","volume":"9","author":"Billy","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.01.016_bib37","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJMoa2107051","article-title":"Adjunct immune globulin for vaccine-induced immune thrombotic thrombocytopenia","volume":"385","author":"Bourguignon","year":"2021","journal-title":"N Engl J Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626000723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626000723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:56:19Z","timestamp":1783972579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626000723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1538783626000723"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.01.016","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of monoclonal and patient-derived antiplatelet factor 4 antibodies in platelet factor 4 and platelet factor 4\/polyanion chemiluminescence assays","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}